title: Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5.
abstract: Hyperphosphorylation of microtubule-associated proteins such as tau and neurofilament may underlie the cytoskeletal abnormalities and neuronal death seen in several neurodegenerative diseases including Alzheimer's disease. One potential mechanism of microtubule-associated protein hyperphosphorylation is augmented activity of protein kinases known to associate with microtubules, such as cdk5 or GSK3beta. Here we show that tau and neurofilament are hyperphosphorylated in transgenic mice that overexpress human p25, an activator of cdk5. The p25 transgenic mice display silver-positive neurons using the Bielschowsky stain. Disturbances in neuronal cytoskeletal organization are apparent at the ultrastructural level. These changes are localized predominantly to the amygdala, thalamus/hypothalamus, and cortex. The p25 transgenic mice display increased spontaneous locomotor activity and differences from control in the elevated plus-maze test. The overexpression of an activator of cdk5 in transgenic mice results in increased cdk5 activity that is sufficient to produce hyperphosphorylation of tau and neurofilament as well as cytoskeletal disruptions reminiscent of Alzheimer's disease and other neurodegenerative diseases.
authors.affiliation: Departments of CNS Discovery, Pathology, and Genetic Technologies, Pfizer Central Research, Eastern Point Road, Groton, CT 06340, USA. michael_k_ahlijanian@groton.pfizer.com
authors.forename: M K
authors.initials: MK
authors.lastname: Ahlijanian
authors.forename: N X
authors.initials: NX
authors.lastname: Barrezueta
authors.forename: R D
authors.initials: RD
authors.lastname: Williams
authors.forename: A
authors.initials: A
authors.lastname: Jakowski
authors.forename: K P
authors.initials: KP
authors.lastname: Kowsz
authors.forename: S
authors.initials: S
authors.lastname: McCarthy
authors.forename: T
authors.initials: T
authors.lastname: Coskran
authors.forename: A
authors.initials: A
authors.lastname: Carlo
authors.forename: P A
authors.initials: PA
authors.lastname: Seymour
authors.forename: J E
authors.initials: JE
authors.lastname: Burkhardt
authors.forename: R B
authors.initials: RB
authors.lastname: Nelson
authors.forename: J D
authors.initials: JD
authors.lastname: McNeish
mesh_terms: D000367:Age Factors; D000544:Alzheimer Disease / Q000378:metabolism / Q000473:pathology; D000818:Animals; D001921:Brain / Q000473:pathology / Q000648:ultrastructure; D000090266:Chromobox Protein Homolog 5; D051360:Cyclin-Dependent Kinase 5; D018844:Cyclin-Dependent Kinases / Q000502:physiology*; D003599:Cytoskeleton / Q000378:metabolism*; D000939:Epitopes; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D008854:Microscopy, Electron; D009419:Nerve Tissue Proteins / Q000378:metabolism*; D016900:Neurofilament Proteins / Q000378:metabolism*; D010766:Phosphorylation; D012737:Sex Factors; D016622:Silver Staining; D016875:tau Proteins / Q000378:metabolism*
chemical_list: C000715594:CBX5 protein, human; D000939:Epitopes; D009419:Nerve Tissue Proteins; D016900:Neurofilament Proteins; C089495:neuronal Cdk5 activator (p25-p35); D016875:tau Proteins; D000090266:Chromobox Protein Homolog 5; D051360:Cyclin-Dependent Kinase 5; C495905:CDK5 protein, human; C495906:Cdk5 protein, mouse; D018844:Cyclin-Dependent Kinases